Point of Care Molecular Diagnostics Market Growth, Demand and Challenges of the Key Industry Players 2024-2032
                     Global Point of Care 
Molecular Diagnostics 
Market Research and 
Forecast Report 2024-
2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
In ternat ional  Market  Analys is  Research and Consul t ing Group is  a leading adv iser  on management  
s t rategy and market  research wor ldwide.  We par tner  wi th c l ients  in  a l l  regions and indust ry  
vert ica ls  to  ident i fy  thei r  h ighest -value oppor tuni t ies,  address thei r  most  cr i t ica l  chal lenges,  and 
t ransform thei r  bus inesses.
IMARC’s in format ion products  inc lude major market ,  sc ient i f ic ,  economic and technological  
developments  for  bus iness leaders  in  pharmaceut ica l ,  indust r ia l ,  and h igh technology 
organizat ions.  Market  forecasts  and indust ry  analys is  for  b iotechnology,  advanced mater ia ls ,  
chemicals ,  food and beverage,  t ravel  and tour ism, nanotechnology and novel  process ing methods 
are at  the top of  the company’s  exper t ise.
IMARC’s ta i lored approach combines unfathomable ins ight  in to the dynamics o f  companies and 
markets wi th c lose cooperat ion at  a l l  levels  of  the c l ient  organizat ion.  This ensures that  our  c l ients 
achieve unmatchable compet i t ive advantage,  bui ld  more pro f ic ient  organizat ions,  and secure 
las t ing resul ts .
Acco r d ing  t o  t he  l a t e s t  r epo r t  by  I M A RC G r ou p ,  t i t l ed  "P o i n t  o f  Care  M o l ecu l a r  
D i agn ost i cs  M ark e t :  G l ob a l  I n dust ry  T r ends ,  Sha re ,  S i ze ,  G row t h ,  O ppo r t un i t y  
and  For ecas t  202 4 - 203 2 , "  t h e  g lob a l  po in t  o f  ca r e  m o le cu la r  d iagn os t i c s  m ar ke t  
s i ze  r eac hed  US$  3 . 7  B i l l i on  i n  2023 .
Report Po in t  o f  ca r e  ( PO C)  m o lecu la r  d iagno s t i cs  i s  a n  ap p r oac h  i n  m ed ica l  t es t i ng  a nd  d iagn os t i cs .  I t  co m pr i ses  a  r ang e  o f  i nnova t i ve  t echn iques  a nd  t e chn o log ies  t ha t  a r e  
des ig ned  t o  p r ov ide  r ap id  and  acc u r a t e  ana l ys i s  o f  b io log i ca l  sam p les ,  su ch  as  
Highlight and b lood ,  u r i ne ,  o r  t i s sue ,  a t  t he  bed s ide  o f  t he  pa t i en t  o r  w i t h in  p r ox i m i t y  t o  t he  
hea l t hca r e  p r o v ide r .  
I t  o f f e r s  r e a l - t im e  and  on - s i t e  t e s t i ng  t ha t  enab les  enha nced  de c i s ion - m a k ing  i n  
Description c l i n i ca l  se t t in gs .  I t  ass i s t s  i n  de t ec t i ng  spec i f i c  gene t i c  m a t e r i a l ,  suc h  as  
deoxy r i bo nuc le i c  a c id  ( D NA)  o r  r i bonu c le i c  a c id  ( R NA) ,  w i t h in  pa t i en t  s am p le s .  As  i t  
a l l ow s  f o r  t he  i den t i f i ca t i on  o f  pa t hoge ns ,  gen e t i c  m u t a t i on s ,  o r  d i s ease  m ar ke r s  a t  
an  e a r l y  s t age ,  t h e  de m and  f o r  PO C m o le cu la r  d iag nos t i c s  i s  r i s i ng  wo r ld w ide .
Reque st  f o r  a  P DF  s ampl e  o f  t h i s  repor t :  
h t t p s : / / www. im ar c g r ou p . com / po i n t - o f - ca r e - m o lecu la r - d iag nos t i cs - m a r ke t / r e ques t sam
p le
Report Description
Global  Point  of  Care Molecular  Diagnost ics Market  Trends:
At  present ,  the increas ing need for  rap id  and prec ise medica l  in format ion to  enhance pat ient  care 
outcomes represents one of  the pr imary fac tors  cont r ibut ing to  the growth of  the market .  Bes ides th is ,  the 
r is ing demand for  POC molecu lar  d iagnost ics,  as  i t  o f fers  h igh accuracy,  is  s t rengthening the market  
growth.  
Moreover ,  the increas ing development  o f  user- f r iend ly  and por tab le  devices and assays for  enhanced 
convenience is  bo ls ter ing the growth of  the market .  Apar t  f rom th is ,  the r is ing focus on persona l ized 
medic ine is  propel l ing the growth of  the market .
Looking forward,  the market  value is  projected to reach US$ 8.4 Bi l l ion by 2032,  expanding at  a  
CAGR of  9 .2% dur ing 2024-2032.
View Report  TOC,  Figures and Tables :  
ht tps: / /www.imarcgroup.com/point -of-care-molecular -diagnost ics-market
Breakup by Product and Service:
• Assays and Ki ts
• Instruments and Analyzers
• Software and Services
 
Breakup by Technology:
• Polymerase Chain React ion (PCR)
Report • Hybridizat ion
• DNA sequencing
Segmentation • Microarray
• Isothermal  Nucleic  Acid Ampl ifi cat ion 
Technology ( INAAT)
• Others
Breakup by Application:
• Infect ious Diseases
• Oncology
• Hematology
• Prenatal  Testing
• Endocrinology
• Others
Breakup by End User:
• Physicians’  Offi ces
• Hospitals and ICUs
Report 
• Research Insti tutes
Segmentation • Others
Breakup by Region:
• North America
• Asia-Pacifi c
• Europe
• Latin America
• Middle East and Afr ica
• Abbott Laboratories
• Becton Dickinson and Company
• Binx Health Inc.
• Co-Diagnostics Inc.
Competitive • F. Hoff mann-La Roche Ltd
Landscape • Gene STAT Molecular Diagnostics LLC
•
with Key Hemocue AB (Danaher Corporation)
• Meridian Bioscience Inc.
Players • Molbio Diagnostics Private Limited
• Quidel Corporation
• Siemens Healthcare GmbH (Siemens AG)
• Thermo Fisher Scientifi c Inc.
• Visby Medical Inc.
What was the size of the global point of care molecular 
diagnostics market in 2023?
What is the expected growth rate of the global point of 
care molecular diagnostics market during 2024-2032?
What are the key factors driving the global point of care 
molecular diagnostics market?
Key 
What has been the impact of COVID-19 on the global 
Questions point of care molecular diagnostics market?
What is the breakup of the global point of care 
Answered in molecular diagnostics market based on the product and service?
the Report What is the breakup of the global point of care 
molecular diagnostics market based on the technology?
What is the breakup of the global point of care 
molecular diagnostics market based on application?
What are the key regions in the global point of care 
molecular diagnostics market?
Who are the key players/companies in the global point 
of care molecular diagnostics market?
1     P r e f a c e
2     S c o p e  a n d  M e t h o d o l o g y
    2 . 1     O b j e c t i v e s  o f  t h e  S t u d y
    2 . 2     S t a k e h o l d e r s
    2 . 3     D a t a  S o u r c e s
        2 . 3 . 1     P r i m a r y  S o u r c e s
        2 . 3 . 2     S e c o n d a r y  S o u r c e s
    2 . 4     M a r k e t  E s t i m a t i o n
        2 . 4 . 1     B o t t o m - U p  A p p r o a c h
Table of         2 . 4 . 2     T o p - D o w n  A p p r o a c h    2 . 5     F o r e c a s t i n g  M e t h o d o l o g y
3     E x e c u t i v e  S u m m a r y
4     I n t r o d u c t i o n
    4 . 1     O v e r v i e w
Contents     4 . 2     K e y  I n d u s t r y  T r e n d s5     G l o b a l  P o i n t  o f  C a r e  M o l e c u l a r  D i a g n o s t i c s  M a r k e t
    5 . 1     M a r k e t  O v e r v i e w
    5 . 2     M a r k e t  P e r f o r m a n c e
    5 . 3     I m p a c t  o f  C O V I D - 1 9
    5 . 4     M a r k e t  F o r e c a s t
6      M a r k e t  B r e a k u p  b y  P r o d u c t  a n d  S e r v i c e
    6 . 1     A s s a y s  a n d  k i t s
        6 . 1 . 1  M a r k e t  T r e n d s
        6 . 1 . 2  M a r k e t  F o r e c a s t
    6 . 2     I n s t r u m e n t s  a n d  A n a l y z e r s
        6 . 2 . 1  M a r k e t  T r e n d s
        6 . 2 . 2  M a r k e t  F o r e c a s t
    6 . 3     S o f t w a r e  a n d  S e r v i c e s
        6 . 3 . 1  M a r k e t  T r e n d s
        6 . 3 . 2  M a r k e t  F o r e c a s t
7     M a r k e t  B r e a k u p  b y  T e c h n o l o g y
       
    7 . 1     P o l y m e r a s e  C h a i n  R e a c t i o n  ( P C R )
        7 . 1 . 1  M a r k e t  T r e n d s
        7 . 1 . 2  M a r k e t  F o r e c a s t
    7 . 2     H y b r i d i z a t i o n
        7 . 2 . 1  M a r k e t  T r e n d s
        7 . 2 . 2  M a r k e t  F o r e c a s t
    7 . 3     D N A  s e q u e n c i n g
        7 . 3 . 1  M a r k e t  T r e n d s
        7 . 3 . 2  M a r k e t  F o r e c a s t
    7 . 4     M i c r o a r r a y
Table of         7 . 4 . 1  M a r k e t  T r e n d s        7 . 4 . 2  M a r k e t  F o r e c a s t
    7 . 5     I s o t h e r m a l  N u c l e i c  A c i d  A m p l i f i c a t i o n  T e c h n o l o g y  ( I N A A T )
        7 . 5 . 1  M a r k e t  T r e n d s
Contents         7 . 5 . 2  M a r k e t  F o r e c a s t    7 . 6     O t h e r s
        7 . 6 . 1  M a r k e t  T r e n d s
        7 . 6 . 2  M a r k e t  F o r e c a s t
8     M a r k e t  B r e a k u p  b y  A p p l i c a t i o n
    8 . 1     I n f e c t i o u s  D i s e a s e s
        8 . 1 . 1  M a r k e t  T r e n d s
        8 . 1 . 2  M a r k e t  F o r e c a s t
    8 . 2     O n c o l o g y
        8 . 2 . 1  M a r k e t  T r e n d s
        8 . 2 . 2  M a r k e t  F o r e c a s t
    8 . 3     H e m a t o l o g y
        8 . 3 . 1  M a r k e t  T r e n d s
        8 . 3 . 2  M a r k e t  F o r e c a s t     
F o r  m o r e  i n f o r m a t i o n ,  v i s i t :  
ht t ps : / /w ww. i ma rc gro up . c o m /p o in t - o f- c a re -m o l ec u l a r-d i a gn os
t i c s -m a rke t / t o c
Disclaimer
© 2023  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
TELEPHONE: +1-631-791-1145 
E-MAIL: [email protected]